Traditional Chinese Medicine Improves Outcomes in HFrEF
In the randomized trial QUEST trial, a traditional Chinese medicine called qiliqiangxin provided significant reductions in CV death and hospitalization on top of guideline-directed therapy in HFrEF.
Source: medscape.com